Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy of Telmisartan and the Combination of Telmisartan and Ramipril in type1 Diabetes Patients With Nephropathy (START1DM)

This study has been completed.
Information provided by:
Postgraduate Institute of Medical Education and Research Identifier:
First received: August 18, 2008
Last updated: August 19, 2008
Last verified: August 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2008
  Primary Completion Date: May 2008 (Final data collection date for primary outcome measure)